Table 5 The frequency of the main reason for which not performing RET according to specialization and country, and chi-squared test.
Difficulty of treatment | Disadvantages of multi-session | I’m not particularly eager to perform regenerative endodontic treatment | Insufficient materials and equipment in the clinic | Lack of cases for regenerative endodontics | Lack of clinical experience/knowledge | Patients’ disapproval of the treatment | Results are not reassuring | Other | |
|---|---|---|---|---|---|---|---|---|---|
Specialization | |||||||||
Endodontics (N = 821) | 39 (4.8%) | 73 (8.9%) | 58 (7.1%) | 81 (9.9%) | 58 (7.1%) | 209 (25.5%) | 165 (20.1%) | 122 (14.9%) | 16 (1.9%) |
Pediatric dentistry (N = 518) | 39 (7.5%) | 50 (9.7%) | 42 (8.1%) | 62 (12%) | 20 (3.9%) | 156 (30.1%) | 85 (16.4%) | 53 (10.2%) | 11 (2.1%) |
p-value | < 0.001 | ||||||||
Country | |||||||||
Croatia (N = 43) | 1 (2.3%) | 2 (4.7%) | 2 (4.7%) | 11 (25.6%) | 5 (11.6%) | 12 (27.9%) | 1 (2.3%) | 8 (18.6%) | 1 (2.3%) |
Egypt (N = 139) | 4 (2.9%) | 15 (10.8%) | 16 (11.5%) | 15 (10.8%) | 11 (7.9%) | 30 (21.6%) | 19 (13.7%) | 25 (18%) | 4 (2.9%) |
India (N = 66) | 1 (1.5%) | 11 (16.7%) | 3 (4.5%) | 4 (6.1%) | 3 (4.5%) | 9 (13.6%) | 16 (24.2%) | 18 (27.3%) | 1 (1.5%) |
Jordan (N = 154) | 11 (7.1%) | 19 (12.3%) | 14 (9.1%) | 29 (18.8%) | 5 (3.2%) | 18 (11.7%) | 25 (16.2%) | 31 (20.1%) | 2 (1.3%) |
Malaysia (N = 117) | 1 (0.9%) | 3 (2.6%) | 17 (14.5%) | 5 (4.3%) | 8 (6.8%) | 11 (9.4%) | 55 (47%) | 17 (14.5%) | 0 (0%) |
Netherlands (N = 55) | 8 (14.5%) | 2 (3.6%) | 4 (7.3%) | 2 (3.6%) | 1 (1.8%) | 18 (32.7%) | 3 (5.5%) | 14 (25.5%) | 3 (5.5%) |
Pakistan (N = 54) | 0 (0%) | 7 (13%) | 2 (3.7%) | 11 (20.4%) | 5 (9.3%) | 6 (11.1%) | 11 (20.4%) | 11 (20.4%) | 1 (1.9%) |
Poland (N = 157) | 31 (19.7%) | 3 (1.9%) | 6 (3.8%) | 1 (0.6%) | 16 (10.2%) | 83 (52.9%) | 17 (10.8%) | 0 (0%) | 0 (0%) |
Portugal (N = 97) | 1 (1%) | 1 (1%) | 26 (26.8%) | 5 (5.2%) | 11 (11.3%) | 20 (20.6%) | 16 (16.5%) | 14 (14.4%) | 3 (3.1%) |
Saudi Arabia (N = 68) | 3 (4.4%) | 3 (4.4%) | 4 (5.9%) | 7 (10.3%) | 4 (5.9%) | 25 (36.8%) | 12 (17.6%) | 7 (10.3%) | 3 (4.4%) |
Serbia (N = 75) | 0 (0%) | 0 (0%) | 0 (0%) | 5 (6.7%) | 0 (0%) | 70 (93.3%) | 0 (0%) | 0 (0%) | 0 (0%) |
Turkey (N = 173) | 8 (4.6%) | 16 (9.2%) | 0 (0%) | 30 (17.3%) | 8 (4.6%) | 36 (20.8%) | 45 (26%) | 21 (12.1%) | 9 (5.2%) |
Yemen (N = 141) | 9 (6.4%) | 41 (29.1%) | 6 (4.3%) | 18 (12.8%) | 1 (0.7%) | 27 (19.1%) | 30 (21.3%) | 9 (6.4%) | 0 (0%) |
p-value | < 0.001 | ||||||||
Total (N = 1339) | 78 (5.8%) | 123 (9.2%) | 100 (7.5%) | 143 (10.7%) | 78 (5.8%) | 365 (27.3%) | 250 (18.7%) | 175 (13.1%) | 27 (2.0%) |
